Question

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

5 comments5

Total Forecasters48

Community Prediction3% (2% - 5%)

Make a Prediction

50%

community: 3%

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says

Forbes•Feb 13, 2025

Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction

Time•Feb 13, 2025

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

Guardian•Feb 18, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

2028-12-07

Comments

? comments

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says

Forbes•Feb 13, 2025

Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction

Time•Feb 13, 2025

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

Guardian•Feb 18, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

2028-12-07